Lowe Brockenbrough & Co’s GSK GSK Stock Holding History

Lowe Brockenbrough & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,670	Closed	-$256K	–	255
2022 Q2	$256K	Sell	4,670 -600	-11%	-$32.9K	0.02%	244
2022 Q1	$291K	Buy	5,270 +640	+14%	+$35.3K	0.02%	240
2021 Q4	$258K	Buy	4,630 +344	+8%	+$19.2K	0.02%	235
2021 Q3	$208K	Hold	4,286	–	–	0.02%	266
2021 Q2	$213K	Buy	+4,286	New	+$213K	0.02%	220
2020 Q4	–	Sell	-4,286	Closed	-$202K	–	213
2020 Q3	$202K	Buy	4,286 +80	+2%	+$3.77K	0.03%	203
2020 Q2	$214K	Sell	4,206 -160	-4%	-$8.14K	0.03%	197
2020 Q1	$207K	Hold	4,366	–	–	0.03%	192
2019 Q4	$256K	Buy	4,366 +160	+4%	+$9.38K	0.03%	197
2019 Q3	$224K	Hold	4,206	–	–	0.03%	204
2019 Q2	$210K	Sell	4,206 -100	-2%	-$4.99K	0.03%	204
2019 Q1	$225K	Hold	4,306	–	–	0.03%	198
2018 Q4	$206K	Hold	4,306	–	–	0.03%	187
2018 Q3	$216K	Hold	4,306	–	–	0.03%	201
2018 Q2	$217K	Sell	4,306 -840	-16%	-$42.3K	0.03%	195
2018 Q1	$251K	Hold	5,146	–	–	0.04%	186
2017 Q4	$228K	Sell	5,146 -400	-7%	-$17.7K	0.03%	189
2017 Q3	$281K	Hold	5,546	–	–	0.04%	180
2017 Q2	$299K	Sell	5,546 -1,751	-24%	-$94.4K	0.05%	171
2017 Q1	$385K	Buy	7,297 +991	+16%	+$52.3K	0.06%	163
2016 Q4	$304K	Hold	6,306	–	–	0.05%	169
2016 Q3	$340K	Sell	6,306 -80	-1%	-$4.31K	0.06%	161
2016 Q2	$346K	Sell	6,386 -8,636	-57%	-$468K	0.06%	159
2016 Q1	$761K	Sell	15,022 -80	-0.5%	-$4.05K	0.13%	127
2015 Q4	$762K	Sell	15,102 -292	-2%	-$14.7K	0.13%	131
2015 Q3	$740K	Sell	15,394 -123	-0.8%	-$5.91K	0.13%	133
2015 Q2	$808K	Buy	15,517 +30	+0.2%	+$1.56K	0.13%	137
2015 Q1	$893K	Sell	15,487 -57	-0.4%	-$3.29K	0.14%	135
2014 Q4	$830K	Buy	15,544 +240	+2%	+$12.8K	0.13%	137
2014 Q3	$879K	Sell	15,304 -700	-4%	-$40.2K	0.14%	126
2014 Q2	$1.07M	Sell	16,004 -88	-0.5%	-$5.88K	0.17%	115
2014 Q1	$1.08M	Sell	16,092 -80	-0.5%	-$5.34K	0.18%	109
2013 Q4	$1.08M	Hold	16,172	–	–	0.18%	111
2013 Q3	$1.01M	Buy	16,172 +60	+0.4%	+$3.76K	0.18%	109
2013 Q2	$1.01M	Buy	+16,112	New	+$1.01M	0.19%	106